TFLLR-NH2 [8259]
TFLLR-NH2
| SMILES | CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O |
| InChIKey | ANAMCEKSRDPIPX-GFGQVAFXSA-N |
| Sequence | TFLLR |
| HELM | PEPTIDE1{T.F.L.L.R.[am]}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 8 |
| Hydrogen bond donors | 10 |
| Rotatable bonds | 20 |
| Log P | -1.283 |
| Molecular weight (Da) | 647.4 |
| Stereochemistry info | unspecified |
Database connections
| Model (AF2) | PAR1 |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
TFLLR-NH2
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
| Model (AF2) | PAR1 |